Tag Archives: contingent value rights

Scorecard Of Biobuck M&A Earnouts
April 30, 2015

Milestone payments are an important risk-sharing component in today’s biopharma deal-making toolbox. As it’s a topic I’ve explored in the past (here, here), it’s an opportune time to revisit the stats for how they have performed recently. These contingent value transfers

Leave a comment